Literature DB >> 14600270

Biglycan and decorin induce morphological and cytoskeletal changes involving signalling by the small GTPases RhoA and Rac1 resulting in lung fibroblast migration.

Ellen Tufvesson1, Gunilla Westergren-Thorsson.   

Abstract

Biglycan and decorin are small chondroitin/dermatan sulphate proteoglycans in the extracellular matrix of connective tissue that belong to the family of structurally related proteoglycans called small leucine-rich repeat proteins. We show for the first time that biglycan and decorin induce morphological and cytoskeletal changes in fibroblasts, resulting in an increase in migration. Biglycan changed the cell shape of fibroblasts with formation of long protruding filamentous processes. This was also seen for decorin but to a lesser extent. Using fluorescence staining of F-actin fibres it was possible to show that these long filamentous processes were supported by long thick bundles of actin, together with an induced formation of stress fibres after stimulation with biglycan and decorin. Moreover, a reorganisation of alpha-smooth muscle actin was clearly seen in these cultures. Decorin also stimulated alpha-smooth muscle actin expression in the cells. Using cDNA Atlas Arrays we were also able to show that the mRNA level of a number of the intracellular regulators and effectors involved in cell migration were increased. For example, the focal adhesion proteins paxillin and zyxin, and some of the small Rho GTPases such as RhoA, Rac1 and Cdc42 were upregulated. After treatment with biglycan or decorin, additional results showed an increased activation of RhoA (1.8- and 1.5-fold, respectively) and Rac1 (1.8- and 1.5-fold, respectively) after 15 minutes. These factors are known to be involved in fibroblast migration, and as expected a 1.3- to 1.6-fold increase in migration could be observed after stimulation with biglycan or decorin. This induced migration was caused by the core protein, as treatment with glycosaminoglycan chains alone did not have any effect. In summary, these data indicate that biglycan- and decorin-induced fibroblast cytoskeletal and signalling changes result in an increased cell migration, and demonstrate their potential role in the remodelling process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600270     DOI: 10.1242/jcs.00808

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  36 in total

Review 1.  Chronic Obstructive Pulmonary Disease and Lung Cancer: Underlying Pathophysiology and New Therapeutic Modalities.

Authors:  Mathew Suji Eapen; Philip M Hansbro; Anna-Karin Larsson-Callerfelt; Mohit K Jolly; Stephen Myers; Pawan Sharma; Bernadette Jones; Md Atiqur Rahman; James Markos; Collin Chia; Josie Larby; Greg Haug; Ashutosh Hardikar; Heinrich C Weber; George Mabeza; Vinicius Cavalheri; Yet H Khor; Christine F McDonald; Sukhwinder Singh Sohal
Journal:  Drugs       Date:  2018-11       Impact factor: 9.546

2.  Perivascular cells of the supraspinatus tendon express both tendon- and stem cell-related markers.

Authors:  Herbert Tempfer; A Wagner; R Gehwolf; C Lehner; M Tauber; H Resch; H C Bauer
Journal:  Histochem Cell Biol       Date:  2009-03-11       Impact factor: 4.304

Review 3.  Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

Authors:  Morten A Karsdal; Tina Manon-Jensen; Federica Genovese; Jacob H Kristensen; Mette J Nielsen; Jannie Marie B Sand; Niels-Ulrik B Hansen; Anne-Christine Bay-Jensen; Cecilie L Bager; Aleksander Krag; Andy Blanchard; Henrik Krarup; Diana J Leeming; Detlef Schuppan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-12       Impact factor: 4.052

Review 4.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

Review 5.  Insights into the key roles of proteoglycans in breast cancer biology and translational medicine.

Authors:  Achilleas D Theocharis; Spyros S Skandalis; Thomas Neill; Hinke A B Multhaupt; Mario Hubo; Helena Frey; Sandeep Gopal; Angélica Gomes; Nikos Afratis; Hooi Ching Lim; John R Couchman; Jorge Filmus; Ralph D Sanderson; Liliana Schaefer; Renato V Iozzo; Nikos K Karamanos
Journal:  Biochim Biophys Acta       Date:  2015-03-28

6.  Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development.

Authors:  Michael S Rafii; Hiroki Hagiwara; Mary Lynn Mercado; Neung S Seo; Tianshun Xu; Tracey Dugan; Rick T Owens; Magnus Hook; David J McQuillan; Marian F Young; Justin R Fallon
Journal:  J Cell Physiol       Date:  2006-11       Impact factor: 6.384

7.  Altered fibroblast proteoglycan production in COPD.

Authors:  Oskar Hallgren; Kristian Nihlberg; Magnus Dahlbäck; Leif Bjermer; Leif T Eriksson; Jonas S Erjefält; Claes-Göran Löfdahl; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2010-05-11

8.  The angiotensin-converting enzyme 2/angiotensin (1-7)/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA/Rho kinase pathway.

Authors:  Ying Meng; Ting Li; Gao-Su Zhou; Yan Chen; Chang-Hui Yu; Miao-Xia Pang; Wei Li; Yang Li; Wen-Yong Zhang; Xu Li
Journal:  Antioxid Redox Signal       Date:  2014-10-02       Impact factor: 8.401

9.  Increased expression of chondroitin sulphate proteoglycans in rat hepatocellular carcinoma tissues.

Authors:  Xiao-Li Jia; Si-Yuan Li; Shuang-Suo Dang; Yan-An Cheng; Xin Zhang; Wen-Jun Wang; Clare E Hughes; Bruce Caterson
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

10.  The matricellular functions of small leucine-rich proteoglycans (SLRPs).

Authors:  Rosetta Merline; Roland M Schaefer; Liliana Schaefer
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.